Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 22 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Modulation of prostate cancer cell attachment to matrix by VersicanSakko, A.; Ricciardelli, C.; Mayne, K.; Suwiwat, S.; LeBaron, R.; Marshall, V.; Tilley, W.; Horsfall, D.
2008Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potentialRicciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.
2001Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionBuchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
2001Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1Sakko, A.; Ricciardelli, C.; Mayne, K.; Tilley, W.; LeBaron, R.; Horsfall, D.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2002A potential autocrine role for vascular endothelial growth factor in prostate cancerJackson, M.; Roberts, J.; Heckford, S.; Ricciardelli, C.; Stahl, J.; Horsfall, D.; Tilley, W.
2004Apolipoprotein-D: A novel cellular marker for HGPIN and prostate cancerHall, R.; Horsfall, D.; Stahl, J.; Vivekanandan, S.; Ricciardelli, C.; Stapleton, A.; Scardino, P.; Neufing, P.; Tilley, W.
2003Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissuesNeufing, P.; Kalionis, B.; Horsfall, D.; Ricciardelli, C.; Stahl, J.; Vivekanandan, S.; Raymond, W.; Tilley, W.
2010Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcomeCallen, D.; Ricciardelli, C.; Butler, M.; Stapleton, A.; Stahl, J.; Kench, J.; Horsfall, D.; Tilley, W.; Schulz, R.; Nesland, J.; Neilsen, P.; Kumar, R.; Holm, R.
1999Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancerRicciardelli, C.; Quinn, D.; Raymond, W.; McCaul, K.; Sutherland, P.; Stricker, P.; Grygiel, J.; Sutherland, R.; Marshall, V.; Tilley, W.; Horsfall, D.